| Literature DB >> 27419199 |
Rongrong Dong1, Fahui Li2, Shucun Qin1, Yi Wang3, Yanhong Si1, Xuelian Xu4, Hua Tian1, Lei Zhai1, Guangjie Zhang1, Yongjun Li1, Yawei Zhou1, Ying Zhang1, Nan Zhang1, Shoudong Guo1.
Abstract
The data presented in this article describe an effect of N-acetylneuraminic acid and/or quercetin on the inflammatory proteins expressions (TNF-α, ICAM-1, VCAM-1 and MOMA-2) and the N-acetylneuraminic acid (NANA) levels of apolipoprotein E-deficient mice that are given a high-fat diet. Protein expression was performed by immunohistochemical imaging and NANA was quantified by liquid chromatography-tandem mass spectrometry (LC-MS/MS) or semi-quantified using Image-Pro Plus software after ligation with fluorescein-5-thiosemicarbazide (FTSC). Further interpretation and discussion could be found at our research article entitled "Exogenous supplement of N-acetylneuraminic acid ameliorates atherosclerosis in apolipoprotein E-deficient mice" (Guo et al., 2016) [1].Entities:
Keywords: Fluorescent labeling; Imaging; Immunohistochemistry; LC-MS/MS; Sialic acid
Year: 2016 PMID: 27419199 PMCID: PMC4936502 DOI: 10.1016/j.dib.2016.06.020
Source DB: PubMed Journal: Data Brief ISSN: 2352-3409
Fig. 1Immunohistochemistry analysis of inflammatory related proteins (n=3). (a), (c), (e), (g) Representative images of immunostained aortic cross-sections by specific antibodies against TNF-α, ICAM-1, VCAM-1 and MOMA-2, respectively (20× magnification; blue color signs nuclei, red or green color signs target protein). (b), (d), (f), (h) Densitometric quantification of TNF-α, ICAM-1, VCAM-1 and MOMA-2, respectively. C: chow diet group; HF: high-fat diet model group; Q: quercetin group; QN: quercetin and N-acetylneuraminic acid combination group; N: N-acetylneuraminic acid group. The data are presented as mean±SD. ## means p<0.01 vs control; * means p<0.05 vs HF and **means p<0.01 vs HF; & means p<0.05 vs quercetin. All of the statistical symbols and the abbreviations are suitable for Fig. 2.
Fig. 2Quantification of NANA by LC-MS/MS and fluorescent staining in situ. (a), Plasma levels of NANA quantified by LC-MS/MS (n=5). (b). Liver NANA levels quantified by LC-MS/MS (n=5). (c) Selective staining NANA in aorta root of apoE mice by fluorescent reagent. (d), Quantification of NANA in aorta root (n=3).
| Subject area | |
| More specific subject area | |
| Type of data | |
| How data was acquired | |
| Data format | |
| Experimental factors | |
| Experimental features | |
| Data source location | |
| Data accessibility |